These same attorneys also have experience advising pharmaceutical companies on pre-regulatory approval activities, FDA regulations, and patent
prosecution strategies which allow the companies to develop the strongest patent portfolio to assert during litigation.
WilmerHale is one of 20 elite law firms named to The National Law Journal's inaugural Intellectual Property Hot List,
which honors firms that demonstrated creative
strategies for litigation, patent
prosecution, licensing or other transactional work in the previous year.